Dimensional Fund Advisors LP Raises Stock Holdings in Health Catalyst, Inc. (NASDAQ:HCAT)

Dimensional Fund Advisors LP raised its holdings in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 17.4% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,591,565 shares of the company's stock after purchasing an additional 235,686 shares during the quarter. Dimensional Fund Advisors LP owned 2.62% of Health Catalyst worth $11,252,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in HCAT. Franklin Resources Inc. raised its position in Health Catalyst by 5.8% in the third quarter. Franklin Resources Inc. now owns 104,141 shares of the company's stock worth $857,000 after acquiring an additional 5,687 shares during the period. Avanza Fonder AB bought a new position in Health Catalyst during the fourth quarter valued at $184,000. SG Americas Securities LLC raised its stake in shares of Health Catalyst by 21.7% in the fourth quarter. SG Americas Securities LLC now owns 27,382 shares of the company's stock valued at $194,000 after buying an additional 4,874 shares during the period. Inspire Investing LLC lifted its position in shares of Health Catalyst by 14.2% during the 4th quarter. Inspire Investing LLC now owns 56,379 shares of the company's stock valued at $399,000 after buying an additional 7,019 shares during the last quarter. Finally, Dynamic Advisor Solutions LLC bought a new position in shares of Health Catalyst during the 4th quarter worth $180,000. 85.00% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of brokerages recently commented on HCAT. Stephens dropped their price target on shares of Health Catalyst from $7.00 to $5.00 and set an "equal weight" rating on the stock in a research note on Thursday, March 6th. Royal Bank of Canada decreased their price target on shares of Health Catalyst from $7.00 to $6.00 and set a "sector perform" rating on the stock in a report on Thursday, February 27th. Stifel Nicolaus lifted their price target on Health Catalyst from $5.00 to $5.50 and gave the stock a "hold" rating in a research note on Thursday, May 8th. Wells Fargo & Company decreased their price target on shares of Health Catalyst from $13.00 to $10.00 and set an "overweight" rating on the stock in a research note on Tuesday, January 21st. Finally, Canaccord Genuity Group cut their price objective on shares of Health Catalyst from $10.00 to $9.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Three investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $8.00.

Insider Buying and Selling at Health Catalyst

In other Health Catalyst news, COO Daniel Lesueur sold 16,902 shares of the firm's stock in a transaction dated Wednesday, March 5th. The shares were sold at an average price of $4.52, for a total transaction of $76,397.04. Following the completion of the sale, the chief operating officer now directly owns 216,250 shares in the company, valued at approximately $977,450. This trade represents a 7.25% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Linda Llewelyn sold 6,441 shares of Health Catalyst stock in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $5.43, for a total transaction of $34,974.63. Following the completion of the transaction, the insider now directly owns 85,819 shares of the company's stock, valued at $465,997.17. This trade represents a 6.98% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 47,588 shares of company stock worth $217,259. 2.50% of the stock is currently owned by company insiders.

Health Catalyst Trading Down 3.5%

Shares of NASDAQ HCAT traded down $0.15 during mid-day trading on Thursday, hitting $4.04. The stock had a trading volume of 109,949 shares, compared to its average volume of 597,778. The firm has a market cap of $283.30 million, a P/E ratio of -2.99 and a beta of 1.56. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.41 and a current ratio of 1.41. The business has a 50 day moving average price of $4.13 and a two-hundred day moving average price of $5.86. Health Catalyst, Inc. has a 1 year low of $3.56 and a 1 year high of $9.24.

Health Catalyst Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.